Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week - Benzinga

Retrieved on: 2021-08-29 13:41:15

Tags for this article:

Articles

Health care

Health sciences

Food and Drug Administration

BioNTech

Economy of New York City

NASDAQ

Pfizer

PDUFA date

Prescription Drug User Fee Act

Agios Pharmaceuticals

Click the tags to see associated articles and topics

Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week - Benzinga. View article details on hiswai:

Excerpt

Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. (NYSE: PFE) ...

Article found on: www.benzinga.com

View Original Article